Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
"Tumor cell cytotoxicity via locally delivered chemotherapeutic agent" does **not refer to a specific molecule or receptor**, but instead describes a therapeutic strategy. This approach involves administering cytotoxic drugs directly into or near tumors to maximize drug concentration at the disease site while minimizing systemic exposure and toxicity. Delivery methods include direct injection, implantable devices, polymer-based pastes or stents coated with chemotherapy agents. The goal is to enhance local control of malignancy—such as after surgical resection—or provide palliative benefit in cases like malignant obstruction[1][9]. Commonly used drugs include methotrexate, doxorubicin, cisplatin and others depending on cancer type[3]. This entry should not be considered a canonical molecular target; it represents an intervention method rather than an individual protein/receptor/enzyme. > "Local application or direct tumor injection of chemotherapeutic drugs has been proposed as a method by which local drug concentrations can be maximized in the immediate tumor environment while systemic exposure and non-target organ toxicity is minimized."[1] > "Traditional chemotherapeutic agents are cytotoxic by means of interfering with cell division... Isolated limb perfusion... have been used to treat some tumors. The main purpose... is to deliver a very high dose... without causing overwhelming systemic damage."[4] This term should be flagged as incorrect for use as a canonical target because it refers broadly to **a mode of therapy** rather than any defined biological molecule suitable for structured database representation.
The mechanism is not a property of a single molecular target but rather the **cytotoxic effect** of various drugs delivered directly to tumor cells. These drugs typically interfere with cell division or induce apoptosis in cancer cells[4][3].
5 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Tumor cell cytotoxicity via locally delivered chemotherapeutic agent.